HUTCHMED (China) (HCM) Curent Deferred Tax Liability (2015 - 2025)
HUTCHMED (China) (HCM) posted quarterly Curent Deferred Tax Liability of $255000.0 for Q4 2025, down 90.59% quarter-over-quarter from $2.7 million in Q4 2022.
HUTCHMED (China) (HCM) Curent Deferred Tax Liability (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has reported Curent Deferred Tax Liability for 9 consecutive years, with $255000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Curent Deferred Tax Liability changed N/A year-over-year to $255000.0; the TTM figure through Dec 2025 stood at $255000.0 (changed N/A YoY), while the FY2025 annual figure was $255000.0, changed N/A from the prior year.
- Curent Deferred Tax Liability eased to $255000.0 in Q4 2025 per HCM's latest filing, from $2.7 million in the prior quarter.
- Across five years, Curent Deferred Tax Liability topped out at $2.8 million in Q4 2021 and bottomed at $255000.0 in Q4 2025.
- Historically, Curent Deferred Tax Liability has averaged $1.9 million across 3 years, with a median of $2.7 million in 2022.
- Annual changes were most pronounced in 2021 — Curent Deferred Tax Liability tumbled 45.39% — and 2022, when it retreated 1.99%.
- HUTCHMED (China)'s Curent Deferred Tax Liability stood at $2.8 million in 2021, then dropped by 1.99% to $2.7 million in 2022, then tumbled by 90.59% to $255000.0 in 2025.
- Business Quant data shows HCM's Curent Deferred Tax Liability at $255000.0 in Q4 2025, $2.7 million in Q4 2022, and $2.8 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax Liability (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | HUTCHMED (China) | 2.18 Bn | 2.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 255,000.00 |
| Dec 31, 2025 | 255,000.00 |
| Dec 31, 2022 | 2.71 Mn |
| Dec 31, 2022 | 2.71 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Dec 31, 2021 | 2.77 Mn |
| Dec 31, 2020 | 5.06 Mn |
| Dec 31, 2020 | 5.06 Mn |
| Dec 31, 2019 | 3.16 Mn |
| Dec 31, 2019 | 3.16 Mn |
| Dec 31, 2018 | 4.84 Mn |
| Dec 31, 2018 | 4.84 Mn |
| Jun 30, 2018 | 5.05 Mn |
| Jun 30, 2018 | 5.05 Mn |
| Dec 31, 2017 | 4.45 Mn |
| Dec 31, 2017 | 4.45 Mn |
| Dec 31, 2016 | 4.00 Mn |
| Dec 31, 2016 | 4.00 Mn |
| Jun 30, 2016 | 2.40 Mn |
| Jun 30, 2016 | 2.40 Mn |